Literature DB >> 23682737

Essential role of NADPH oxidase-dependent reactive oxygen species generation in regulating microRNA-21 expression and function in prostate cancer.

Sarvesh Jajoo1, Debashree Mukherjea, Tejbeer Kaur, Kelly E Sheehan, Sandeep Sheth, Vikrant Borse, Leonard P Rybak, Vickram Ramkumar.   

Abstract

AIMS: Oncogenic microRNAs (miRs) promote tumor growth and invasiveness. One of these, miR-21, contributes to carcinogenesis in prostate and other cancers. In the present study, we tested the hypothesis that NADPH oxidase-dependent reactive oxygen species (ROS) regulate the expression and function of miR-21 and its target proteins, maspin and programmed cell death 4 (PDCD4), in prostate cancer cells.
RESULTS: The highly aggressive androgen receptor negative PC-3M-MM2 prostate cancer cells demonstrated high expression of miR-21 and p47(phox) (an essential subunit of NADPH oxidase). Using loss-of-function strategy, we showed that transfection of PC-3M-MM2 cells with anti-miR-21- and p47(phox) siRNA (si-p47(phox)) led to reduced expression of miR-21 with concurrent increase in maspin and PDCD4, and decreased the invasiveness of the cells. Tail-vein injections of anti-miR-21- and si-p47(phox)-transfected PC-3M-MM2 cells in severe combined immunodeficient mice reduced lung metastases. Clinical samples from patients with advanced prostate cancer expressed high levels of miR-21 and p47(phox), and low expression of maspin and PDCD4. Finally, ROS activated Akt in these cells, the inhibition of which reduced miR-21 expression. INNOVATION: The levels of NADPH oxidase-derived ROS are high in prostate cancer cells, which have been shown to be involved in their growth and migration. This study demonstrates that ROS produced by this pathway is essential for the expression and function of an onco-miR, miR-21, in androgen receptor-negative prostate cancer cells.
CONCLUSION: These data demonstrate that miR-21 is an important target of ROS, which contributes to the highly invasive and metastatic phenotype of prostate cancer cells.

Entities:  

Mesh:

Substances:

Year:  2013        PMID: 23682737      PMCID: PMC3852344          DOI: 10.1089/ars.2012.4820

Source DB:  PubMed          Journal:  Antioxid Redox Signal        ISSN: 1523-0864            Impact factor:   8.401


  58 in total

1.  PDCD4 nuclear loss inversely correlates with miR-21 levels in colon carcinogenesis.

Authors:  Matteo Fassan; Marco Pizzi; Luciano Giacomelli; Claudia Mescoli; Kathrin Ludwig; Salvatore Pucciarelli; Massimo Rugge
Journal:  Virchows Arch       Date:  2011-01-29       Impact factor: 4.064

2.  MicroRNA-21 promotes the cell proliferation, invasion and migration abilities in ovarian epithelial carcinomas through inhibiting the expression of PTEN protein.

Authors:  Yanhui Lou; Xingsheng Yang; Fuling Wang; Zhumei Cui; Yu Huang
Journal:  Int J Mol Med       Date:  2010-12       Impact factor: 4.101

3.  The transformation suppressor Pdcd4 is a novel eukaryotic translation initiation factor 4A binding protein that inhibits translation.

Authors:  Hsin-Sheng Yang; Aaron P Jansen; Anton A Komar; Xiaojing Zheng; William C Merrick; Sylvain Costes; Stephen J Lockett; Nahum Sonenberg; Nancy H Colburn
Journal:  Mol Cell Biol       Date:  2003-01       Impact factor: 4.272

4.  Adenosine A(3) receptor suppresses prostate cancer metastasis by inhibiting NADPH oxidase activity.

Authors:  Sarvesh Jajoo; Debashree Mukherjea; Kounosuke Watabe; Vickram Ramkumar
Journal:  Neoplasia       Date:  2009-11       Impact factor: 5.715

5.  miR-27b*, an oxidative stress-responsive microRNA modulates nuclear factor-kB pathway in RAW 264.7 cells.

Authors:  Sivasubramani Thulasingam; Chandirasegaran Massilamany; Arunakumar Gangaplara; Hongjiu Dai; Shahlo Yarbaeva; Sakthivel Subramaniam; Jean-Jack Riethoven; James Eudy; Marjorie Lou; Jay Reddy
Journal:  Mol Cell Biochem       Date:  2011-02-25       Impact factor: 3.396

6.  Programmed cell death 4 (PDCD4) is an important functional target of the microRNA miR-21 in breast cancer cells.

Authors:  Lisa B Frankel; Nanna R Christoffersen; Anders Jacobsen; Morten Lindow; Anders Krogh; Anders H Lund
Journal:  J Biol Chem       Date:  2007-11-08       Impact factor: 5.157

7.  Maspin, a serpin with tumor-suppressing activity in human mammary epithelial cells.

Authors:  Z Zou; A Anisowicz; M J Hendrix; A Thor; M Neveu; S Sheng; K Rafidi; E Seftor; R Sager
Journal:  Science       Date:  1994-01-28       Impact factor: 47.728

8.  MicroRNA-21 targets tumor suppressor genes in invasion and metastasis.

Authors:  Shuomin Zhu; Hailong Wu; Fangting Wu; Daotai Nie; Shijie Sheng; Yin-Yuan Mo
Journal:  Cell Res       Date:  2008-03       Impact factor: 25.617

Review 9.  Role of oxidative stress response elements and antioxidants in prostate cancer pathobiology and chemoprevention--a mechanistic approach.

Authors:  Suresh C Sikka
Journal:  Curr Med Chem       Date:  2003-12       Impact factor: 4.530

10.  MicroRNA-21 directly targets MARCKS and promotes apoptosis resistance and invasion in prostate cancer cells.

Authors:  Tao Li; Dong Li; Jianjun Sha; Peng Sun; Yiran Huang
Journal:  Biochem Biophys Res Commun       Date:  2009-03-18       Impact factor: 3.575

View more
  25 in total

1.  Mitochondrial Haplotype of the Host Stromal Microenvironment Alters Metastasis in a Non-cell Autonomous Manner.

Authors:  Amanda E Brinker; Carolyn J Vivian; Thomas C Beadnell; Devin C Koestler; Shao Thing Teoh; Sophia Y Lunt; Danny R Welch
Journal:  Cancer Res       Date:  2019-12-17       Impact factor: 12.701

Review 2.  The epigenetic landscape related to reactive oxygen species formation in the cardiovascular system.

Authors:  Thomas Kietzmann; Andreas Petry; Antonina Shvetsova; Joachim M Gerhold; Agnes Görlach
Journal:  Br J Pharmacol       Date:  2017-05-10       Impact factor: 8.739

3.  Expression and clinical significance of microRNA-21, maspin and vascular endothelial growth factor-C in bladder cancer.

Authors:  Hui-Hui Zhang; Fan Qi; You-Han Cao; Xiong-Bing Zu; Min-Feng Chen
Journal:  Oncol Lett       Date:  2015-07-28       Impact factor: 2.967

Review 4.  Overview upon miR-21 in lung cancer: focus on NSCLC.

Authors:  Cecilia Bica-Pop; Roxana Cojocneanu-Petric; Lorand Magdo; Lajos Raduly; Diana Gulei; Ioana Berindan-Neagoe
Journal:  Cell Mol Life Sci       Date:  2018-07-20       Impact factor: 9.261

Review 5.  MicroRNAs: The Link between the Metabolic Syndrome and Oncogenesis.

Authors:  Adriana Fodor; Andrada Luciana Lazar; Cristina Buchman; Brandusa Tiperciuc; Olga Hilda Orasan; Angela Cozma
Journal:  Int J Mol Sci       Date:  2021-06-13       Impact factor: 5.923

Review 6.  From inflammatory bowel disease to colorectal cancer: what's the role of miRNAs?

Authors:  Mostafa Vaghari-Tabari; Niloufar Targhazeh; Soheila Moein; Durdi Qujeq; Forough Alemi; Maryam Majidina; Simin Younesi; Zatollah Asemi; Bahman Yousefi
Journal:  Cancer Cell Int       Date:  2022-04-11       Impact factor: 5.722

7.  Activation and regulation of the granulation tissue derived cells with stemness-related properties.

Authors:  Zelin Chen; Tingyu Dai; Xia Chen; Li Tan; Chunmeng Shi
Journal:  Stem Cell Res Ther       Date:  2015-04-29       Impact factor: 6.832

8.  Oncogenic transformation of human lung bronchial epithelial cells induced by arsenic involves ROS-dependent activation of STAT3-miR-21-PDCD4 mechanism.

Authors:  Poyil Pratheeshkumar; Young-Ok Son; Sasidharan Padmaja Divya; Lei Wang; Zhuo Zhang; Xianglin Shi
Journal:  Sci Rep       Date:  2016-11-23       Impact factor: 4.379

9.  Interplay between Reactive oxygen Species and MicroRNAs in Cancer.

Authors:  Jun He; Bing-Hua Jiang
Journal:  Curr Pharmacol Rep       Date:  2016-02-09

10.  Insulin regulates glucose consumption and lactate production through reactive oxygen species and pyruvate kinase M2.

Authors:  Qi Li; Xue Liu; Yu Yin; Ji-Tai Zheng; Cheng-Fei Jiang; Jing Wang; Hua Shen; Chong-Yong Li; Min Wang; Ling-Zhi Liu; Bing-Hua Jiang
Journal:  Oxid Med Cell Longev       Date:  2014-05-08       Impact factor: 6.543

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.